The World Orphan Drug Congress Europe returns 27-29 October 2025 as the
largest and most established orphan drug & rare disease meeting of its kind!
From cell and gene therapy, genetic testing, and market access, to real world evidence, this one meeting covers the whole orphan drugs value chain where science, government and manufacturers all come together to create groundbreaking progress.
Limited FREE passes
are available for Sanofi employees in France and Netherlands, granting full access to the conference, including the workshop day, networking app and drink receptions.
Please note: all applications are subject to Terrapinn approval and availability. We also have the right to decline or withdraw your application at any time.
Sanofi will be contributing sessions across the
entire programme
– see who will be speaking below:
28 October
11:30
Alicia Granados
Global Health Scientific Advocacy & Insights Medical Affairs, Rare Diseases
Working Group
Involving Rare Diseases Patients in Clinical Guidelines’
Development
Development
29 October
12:15
Alicia Granados
Global Health Scientific Advocacy & Insights Medical Affairs, Rare Diseases
Access & Pricing
How do you assess evidence in Rare? The work of HTAi RDIG
15:00
Anne-Sophie Chalandon
Head of Rare Diseases Global Public Affairs Rare Disease and ATMP Policy at Sanofi, and leading the IFPMA Rare Diseases Group
Keynote Panel: In what way can we mobilise, enable and leverage international policies around the world for PLWRDs?
Offer applies to Sanofi employees only. All guest pass applications subject to Terrapinn approval.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events